Reprint Citations for National LMS :

        (Dave Blask & Bob Dauchy)

1.                  Sauer, L.A., Stayman, J. Webster III, and Dauchy, R.T.  Amino acid, glucose and lactic acid utilization in vivo by rat tumors.  Cancer Res.  42:  4090-4097, 1982.

2.                  Sauer, L.A., and Dauchy, R.T.   Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats.  Cancer Res.  43: 3497-3503, 1983.

3.                  Sauer, L.A., and Dauchy, R.T.  Regulation of lactate production and utilization in rat tumors in vivo.  J. Biol. Chem.  260(12):  7496-7501, 1985.

4.                  Dauchy, R.T., and Sauer, L.A.  Preparation of “tissue-isolated” rat tumors for perfusion:  A new surgical technique that preserves continuous blood flow.  Lab. Animal Science. 36(6):  678-681, 1985.

5.                  Dauchy, R.T., Sauer, L.A., and Blask, D.E.  Light contamination during the dark phase in photoperiodically-controlled animal facilities:  Effect on tumor growth and metabolism in rats.  Lab. Animal Science. 47(5):  511-518, 1997.

6.                  Sauer, L.A., Dauchy, R.T., and Blask, D.E.  Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in Hepatoma 7288CTC in Buffalo rats. J. Nutrition. 127: 1412-1421, 1997.

7.                  Blask, D.E., Dauchy, R.T., and Sauer, L.A., Holowachuk, E., Ruhoff, M., and Kopff, H.  Melatonin inhibition of cancer growth in Vivo involves suppression of tumor fatty acid metabolism receptor-mediated signal transduction events.  Cancer Res. 59:  4693-4701, 1999.

8.                  Sauer, L.A., Dauchy, R.T., Blask, D.E., Armstrong, B., and Scalici, S.  13-Hydroxyoctadecadienoic Acid is the mitogenic signal for linoleic acid-dependent growth in rat Hepatoma 7288CTC in Vivo.  Cancer Res. 59: 4688-4692, 1999.

9.                  Blask, D.E., Sauer, L.A., and Dauchy, R.T.  Melatonin as chronobiotic/anticancer

            agent: Cellular, biochemical, and molecular mechanisms of action and their   

            implications for circadian-based cancer therapy.  Current Top. in Med. Chem.  2:

           113-132, 2002.

10.              Blask, D.E., Dauchy, R.T. Sauer, L.A., Krause, J.A., and Brainard, G.C. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: Impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Research. Treat., 79: 313-320, 2003.